A 1210477

Discontinued Product

A 1210477 (Cat. No. 6409) has been withdrawn from sale for commercial reasons.
Description: Selective, high affinity Mcl-1 inhibitor; proapoptotic
Chemical Name: 7-[5-[[4-[4-[(Dimethylamino)sulfonyl]-1-piperazinyl]phenoxy]methyl]-1,3-dimethyl-1H-pyrazol-4-yl]-1-[2-(4-morpholinyl)ethyl]-3-[3-(1-naphthalenyloxy)propyl]-1H-indole-2-carboxylic acid
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature (2)
Pathways (1)

Biological Activity for A 1210477

A 1210477 is a selective, high affinity Mcl-1 inhibitor (Ki = 454 pM). Disrupts Mcl-BIM complexes (IC50 in low μM range). Also inhibits Mcl-1NOXA interactions. Exhibits no effect on Bcl-XL-Bim or Bcl-X-BCL-Xs interactions. Induces apoptosis in multiple myeloma and non-small cell lung cancer cell lines and exhibits a synergistic effect with NavitoclaxTM to induce apoptosis in vitro. Cell permeable.

Technical Data for A 1210477

M. Wt 850.04
Formula C46H55N7O7S
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 1668553-26-1
PubChem ID 66575373
InChI Key XMVAWGSQPHFXKU-UHFFFAOYSA-N
Smiles CN(C)S(=O)(=O)N1CCN(CC1)C1=CC=C(OCC2=C(C(C)=NN2C)C2=C3N(CCN4CCOCC4)C(C(O)=O)=C(CCCOC4=CC=CC5=C4C=CC=C5)C3=CC=C2)C=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for A 1210477

References are publications that support the biological activity of the product.

Bruncko et al (2015) Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity. J.Med.Chem. 58 2180 PMID: 25679114

Leverson et al (2015) Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). Cell Death Dis. 6 e1590 PMID: 25590800

View Related Products by Target

View Related Products by Product Action

View all Bcl-2 Family Inhibitors

Keywords: A 1210477, A 1210477 supplier, A1210477, Mcl-1, inhibitors, inhibits, apoptosis, proapoptotic, selective, high, affinity, multiple, myeloma, non-small, cell, lung, cancer, Bcl-2, Family, 6409, Tocris Bioscience

Citations for A 1210477

Citations are publications that use Tocris products.

Currently there are no citations for A 1210477.

Reviews for A 1210477

There are currently no reviews for this product. Be the first to review A 1210477 and earn rewards!

Have you used A 1210477?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.

Programmed Cell Death Poster

Programmed Cell Death Poster

There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.

Pathways for A 1210477

Apoptosis Signaling Pathway

Apoptosis Signaling Pathway

Apoptosis is a physiological process for cell death that is critical during aging and development. It may also be referred to as cell 'suicide'. Apoptosis can be triggered by events both inside and outside of the cell.